Fabry disease
Biotech

Cash-strapped Sangamo seeks partner for new gene therapy

Sangamo Therapeutics’ investigational gene therapy appears to improve kidney function at 52 weeks for patients with a rare genetic disorder.
Gabrielle Masson Jun 24, 2025 11:53am
An artists illustration of a neuron with electrical pulses used here to illustrate nerve conduction in neuropathy

Tissium snags FDA de novo clearance for sutureless nerve repair

Jun 24, 2025 11:45am
ForSight Robotics

ForSight Robotics raises $125M to trial eye surgery platform

Jun 24, 2025 11:40am
liver transplant

Rivus weight loss drug shows MASH win, muscle-sparing potential

Jun 24, 2025 10:07am
obesity drugs

MindRank reports 10% weight loss on oral GLP-1 drug in phase 2b

Jun 24, 2025 10:06am
positive negative up down good bad mixed

Amgen's ph. 3 MariTide study will ramp up dosing to quell nausea

Jun 24, 2025 9:59am
More News

Stuart sees dry eye disease drug fail ph. 3 study, plans another

Jun 24, 2025 9:26am

Nektar stock doubles as phase 2b eczema trial hits endpoints

Jun 24, 2025 9:20am

Royalty signs off $2B to bankroll Revolution's RAS cancer drug

Jun 24, 2025 9:00am

Nuvalent trots out strong pivotal data in FDA lung cancer push

Jun 24, 2025 6:30am